| Typicality: | 0.411 |
| Saliency: | 0.352 |
| with cell all | 5 | other |
| with spinal muscular atrophy | 4 | other |
| simultaneously | 3 | manner |
| drug → be approved for → child | 29 |
| drug → be approved to treat → child | 8 |
| drug → be approved for → pediatric use | 5 |
| negative | neutral | positive |
| 0.157 | 0.475 | 0.367 |
| Raw frequency | 42 |
| Normalized frequency | 0.352 |
| Modifier score | 0.533 |
| Perplexity | 90.565 |